Related Experiment Video
Updated: Jan 25, 2026

Detection of Lung Tumor Progression in Mice by Ultrasound Imaging
Published on: February 27, 2020
ALDH2 Repression Promotes Lung Tumor Progression via Accumulated Acetaldehyde and DNA Damage
Kaimi Li1, Wenzheng Guo1, Zhanming Li2
1Key Laboratory of Cell Differentiation and Apoptosis of Chinese Minister of Education, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Shanghai Key Laboratory for Tumor Microenvironment and Inflammation, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Abstract:
The major role of aldehyde dehydrogenase 2 family (ALDH2) is to detoxify acetaldehyde (ACE) to non-toxic acetic acid. Many evidences suggest that ALDH2 dysfunction contributes to a variety of human diseases including cancer. However, the biological function and molecular mechanism of ALDH2 in tumor progression remain elusive. In this study, we found that ALDH2 repression was associated with poor prognosis in lung adenocarcinoma. Overexpression of ALDH2 inhibited malignant features of lung adenocarcinoma cells, such as proliferation, stemness and migration, whereas ALDH2 knockdown increased these features. Mechanistically, ALDH2 repression led to accumulation of ACE; whereas ACE enhanced the migration features of lung adenocarcinoma cells, which was associated with increased DNA damage. Importantly, accumulated ACE and increased DNA damage were identified in Aldh2-knockout (KO) mouse lung tissues in vivo. Consistent with this concept, treatment of lung adenocarcinoma cells with ALDH2 agonist Alda-1 suppressed the proliferation, stemness and migration features of lung adenocarcinoma cells. Thus, activating ALDH2, such as via its agonist, may provide a novel strategy for treatment of lung cancer.
Insights
Aldehyde dehydrogenase 2 (ALDH2) normally detoxifies acetaldehyde. Its reduced function in lung cancer promotes tumor growth and migration by increasing acetaldehyde, suggesting ALDH2 activation as a potential cancer therapy.
Area of Science:
- Biochemistry
- Oncology
- Molecular Biology
Background:
- Aldehyde dehydrogenase 2 (ALDH2) is crucial for detoxifying acetaldehyde (ACE).
- ALDH2 dysfunction is implicated in various diseases, including cancer, but its role in tumor progression is not fully understood.
Purpose of the Study:
- To investigate the biological function and molecular mechanisms of ALDH2 in lung adenocarcinoma progression.
- To explore the potential of ALDH2 activation as a therapeutic strategy for lung cancer.
Main Methods:
- Analysis of ALDH2 expression in lung adenocarcinoma patient data.
- In vitro studies involving ALDH2 overexpression and knockdown in lung adenocarcinoma cell lines.
- In vivo studies using Aldh2-knockout mouse models.
- Treatment of cell lines with the ALDH2 agonist Alda-1.
Main Results:
- ALDH2 repression correlated with poor prognosis in lung adenocarcinoma.
- ALDH2 overexpression suppressed proliferation, stemness, and migration; knockdown enhanced these features.
- ALDH2 repression led to ACE accumulation, which promoted cell migration and DNA damage.
- ACE accumulation and DNA damage were observed in Aldh2-knockout mouse lungs.
- Alda-1 treatment inhibited malignant cell features.
Conclusions:
- ALDH2 plays a tumor-suppressive role in lung adenocarcinoma by detoxifying ACE and preventing DNA damage.
- Activating ALDH2, for example, with Alda-1, may represent a novel therapeutic approach for lung cancer.
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Repressed Memory
The Eukaryotic Promoter Region
Repressible Operon: trp Operon

